CTRI/2012/04/002550已完成未知
A comparative study of antiproteinuric effect of Ramipril versus Telmisartan in Diabetic nephropathy with concomitant hypertension in a tertiary care hospital.
Sowmya Bondalapati0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All IP/OP diagnosed with Type II DM with concomitant mild to moderate hypertension associated with albuminuria detected by dip stick method.
- •DN patients either on Insulin / Oral hypoglycemics.
排除标准
- •Age 30 and 65 years of either sex
- •Patients diagnosed with Type I DM/ IDDM
- •Patients with severe hypertension.
- •Patients with proteinuria who are on dialysis/ renal transplant
- •Patients with H/O concomitant illness: TB/ CHF/ BA/ Epilepsy/ Ascites.
- •Pregnant / lactating women
- •Patients with H/O of other causes of proteinuria like analgesic nephropathy, nephrolithiasis, renal malignancies, metastasis to kidney, UTI, SLE, PKD.
研究者
相似试验
已完成
2 期
Effect of pentoxifylline on urinary protein excretion reduction in diabetic nephropathy patients.Condition 1: Non-insulin-dependent diabetes mellitust. Condition 2: Diabetic Nephropathy.Non-insulin-dependent diabetes mellitusGlomerular disorders in diabetes mellitusIRCT138901013596N1research deputy of Ahvaz Jundishapur University100
招募中
不适用
Comparison of anti-proteinuric effects of febuxostat and conventional therapies for hyperuricemia in patients with chronic kidney disease: an open-label randomized controlled trialHyperuricemia, chronic kidney diseaseJPRN-UMIN000009942Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine70
已完成
4 期
antiproteinuric and antiinflammatory effect of vitamin D comparing with direct renin inhibitor in DKDAge > 18DKD with eGFR > 15 ml/min Optimal dose of ACEI or ARB 𕟵 monthsStable BP control ( ΔSBP 󖼚% )Stable renal function ( ΔeGFR 󖼚% )Stable glycemic cvitamin D ,Direct renin inhibitor ,diabetic kidney diseaseTCTR20120000008avamindhradhiraj university39
已完成
不适用
Antiproteinuric effect of recombinant human erythropoietin (rHuEPO) in predialysis chronic kidney disease (CKD) patients: multicenter observational studyPredialysis CKD patients treated with recombinant human erythropoietin (rHuEPO)JPRN-UMIN000001634Osaka General Medical Center Department of Kidney Disease and Hypertension50
已完成
4 期
A RESEARCH STUDY EVALUATING PROTEINURIA I.E. PROTEINS IN THE URINE REDUCING EFFICACY OF ANGIOTENSIN RECEPTOR BLOCKERS LOSARTAN, TELMISARTAN AND OLMESARTACTRI/2011/05/001765il150